![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 22, 19538-19545, May 31, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Department of Biochemistry, Biophysics, and Molecular Biology, Iowa State University, Ames, Iowa 50011
Received for publication, February 26, 2002, and in revised form, March 12, 2002
| |
ABSTRACT |
|---|
|
|
|---|
We have identified a new human hemoglobin that we
call histoglobin because it is expressed in a wide array of tissues.
Histoglobin shares less than 30% identity with the other human
hemoglobins, and the gene contains an intron in an unprecedented
location. Spectroscopic and kinetic experiments with recombinant human
histoglobin indicate that it is a hexacoordinate hemoglobin with
significantly different ligand binding characteristics than the other
human hexacoordinate hemoglobin, neuroglobin. In contrast to the very high oxygen affinities displayed by most hexacoordinate hemoglobins, the biophysical characteristics of histoglobin indicate that it could
facilitate oxygen transport. The discovery of histoglobin demonstrates
that humans, like plants, differentially express multiple
hexacoordinate hemoglobins.
Hemoglobins (Hbs)1 are a
class of proteins long associated with functions in respiration and the
storage and transport of oxygen. Recent research has also focused upon
a potential physiological role of Hb relating to its interactions with
nitric oxide (NO) during conditions of oxidative stress. Several
examples of physiologically important reactions involving Hb and NO now
exist: 1) Bacterial and yeast flavohemoglobins scavenge NO resulting
from oxidative bursts, protecting these cells from the host immune
response to infection (1-3). 2) A critical hindrance to cell-free
Hb-based blood substitutes is the severe hypertension resulting from
their scavenging of NO (4). 3) NO is scavenged by myoglobin (Mb) in
cardiac tissue (5, 6). 4) The Hb from the parasitic worm Ascaris is reported to function as an NO-activated
dioxygenase (7). 5) Mycobacterium tuberculosis contains a
truncated Hb that is reported to be an NO scavenger (8). 6) The binding of NO to human Hb thiols has been implicated in vascular control (9).
In addition, there is mounting evidence that Hbs are involved in cell
survival during hypoxia. Human neuroglobin (NGb) has recently been
linked to tissue protection during hypoxic ischemia injury (10), and
similar low oxygen conditions induce the expression of a ubiquitous
nonsymbiotic plant Hb (11, 12).
Both NGb and nonsymbiotic plant Hbs are members of a newly discovered
class of "hexacoordinate" Hbs (hxHbs) that have been found in
animals (13, 14), protists (15), cyanobacteria (16-18), and all plants
(19, 20). In addition to potentially new physiological functions, hxHbs
use an alternative mechanism to regulate ligand binding which involves
reversible intramolecular coordination of the heme iron; prior to the
discovery of this mechanism, an open coordination site was believed
necessary for reversible ligand binding in Hbs (Fig.
1). Despite this apparent hindrance to
entering ligands, hxHbs are capable of reversibly binding oxygen and
other heme ligands with unusually high affinities (21). The molecular
details of the hexacoordination mechanism are not known with certainty.
Biophysical examination of the details of this reaction is necessary to
distinguish whether hexacoordination is a mechanism for regulating
ligand affinity or a requirement for a novel biochemical reaction.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (17K):
[in a new window]
Fig. 1.
Heme coordination states. A,
pentacoordinate heme; B, hexacoordinate heme. Two His side
chains coordinate the heme iron in hxHbs.
Despite the prevalence of hxHbs, the physiological function(s) of these
proteins is unknown. However, there is growing evidence linking hxHbs
with NO scavenging and a protective role during hypoxia (10, 21). If
hxHbs serve to protect cells from damage during the generation of NO or
other reactive oxygen species, their expression in a wide range
of tissues could be expected. Plants are known to contain two or three
different hxHbs expressed in a variety of tissues (11, 12), but the
human hxHb NGb is essentially expressed only in the brain (14). When
coupled with a link to hypoxia in plant hxHbs and NGb, this suggests
that humans may harbor more than one hxHb. Our inquiry into this
possibility has led to the discovery of histoglobin (HGb), a hxHb
expressed ubiquitously in human tissues with behavior unique compared
with the other human Hbs.
| |
EXPERIMENTAL PROCEDURES |
|---|
|
|
|---|
Identification, Cloning, and Sequence Analysis--
The HGb gene
was identified utilizing ALLGENE (22) to mine the publicly available
express sequence tag (EST) and genomic sequencing data on Mus
musculus and Homo sapiens for predicted genes harboring
a globin domain. The resulting data were reduced by selection for genes
with a GenBank identified EST clone. Of the remaining candidate genes,
all coding for proteins containing more than 250 residues were culled
because currently identified hxHbs are composed of ~200 or fewer
amino acids. The final candidates were then evaluated based on sequence
homology with the vertebrate Hbs to eliminate those likely originating
from splicing errors of the known globin genes. This process identified
the putative gene DT.40262016 (ALLGENE identification number) as a
potential novel mammalian Hb. The IMAGE EST clone R87866 corresponding to DT.40262016 was purchased from Incyte Genomics. The human HGb cDNA sequence was found through sequencing of R87866. Intron determination and chromosome localization were performed using the
public human genome data base. The complete cDNA sequence has been
posted by the NCBI annotation project (accession no. XM058818).
Oligonucleotide primers were designed to incorporate NdeI
and EcoRI restriction sites at the 5'- and 3'-ends of the gene, respectively. The HGb cDNA was synthesized by PCR using these
primers and then cloned into the Novagen expression vectors pET29a
(no-tag) and pET28a (His6-tagged) to generate constructs for recombinant protein generation. The protein alignment (Fig. 2A) was generated using the
ClustalW algorithm and cross-checked against previously published
sequence alignments of the human Hbs.
|
Recombinant Protein Generation and Spectroscopy--
Human HGb
was expressed in Z-competent (Zymo Research) Escherichia
coli BL21(
DE3)-CodonPlus-RP cells (Stratagene), using both a
previously described fermentation apparatus (23) and 2-liter culture
flasks. Recombinant expression cultures were grown at 37 °C for a
period of 14-16 h postinoculation in 2× YT nutrient medium
supplemented with 50 µg/ml kanamycin. These cultures were harvested
by centrifugation, and the cells were lysed with two passages through
an Avestin EmulsiFlex-C5 homogenizer at 25,000 p.s.i.
The nontagged HGb was purified from lysate using a four-stage process composed of ammonium sulfate fractionation (40 and 70%), phenyl-Sepharose column chromatography (1.5 M (NH4)2SO4 binding, 0.75 M (NH4)2SO4 elution), DEAE-cellulose column chromatography (0 mM NaCl binding, 50 mM NaCl elution), and a final size exclusion chromatography step (Sephacryl S-200). The protein solution was dialyzed into 20 mM Tris, pH 8.0, after the phenyl-Sepharose separation and before the DEAE-cellulose purification step. The His6-tagged protein was purified using an affinity column (nickel-nitrilotriacetic acid) followed by a desalting column (G-25). Purification was at 4 °C, and a protease inhibitor mixture (Sigma) was included in the lysis buffers (50 mM Tris, 1 mM dithiothreitol, pH 8.0; nontagged HGb, 50 mM KPO4, 5 mM imidazole, pH 7.5; His6-tagged HGb) and other purification buffers, except that used in the final size exclusion or desalting step (100 mM KPO4, pH 7.0).
All protein experiments were initially conducted in quadruplicate, utilizing His6-tagged and nontagged green and red HGb. All species of HGb exhibited functionally identical behavior, excluding the obvious spectral difference between the green and red protein samples. In light of this, further replications were conducted using the red versions of the protein, with the exception of those experiments explicitly describing the green protein. Reduced protein spectra were obtained in N2-sparged sample buffer after reduction of the protein with sodium dithionite.
RNA Hybridization Assay-- A human adult normal tissue RNA Dot-Blot I (BioChain Institute) was screened using 32P-labeled probes generated with random hexamer primers and HGb or NGb cDNA. Hybridization buffer consisted of PerfectHYB Plus (Sigma) with 0.1 mg/ml sheared, denatured salmon testis DNA as a blocking reagent. The membrane was prehybridized for 1 h at 60 °C, and hybridization was allowed to proceed for 12 h at 60 °C. The membrane was washed once (2× SSC, 0.1% SDS) for 5 min at 25 °C, followed by two washes (0.5× SSC, 0.1% SDS) for 20 min at 60 °C and a final wash (0.1× SSC, 0.1% SDS) for 10 min at 60 °C. The membrane was then sealed in saran wrap and exposed to a PhosphoImager for 30 h. The membrane was first probed with HGb, then stripped, and the identical procedure outlined above was repeated using the probe generated from NGb. The NGb hybridized membrane required a 48-h exposure to the PhosphoImager.
Oxygen Sensitivity/Heme Exchange Experiments-- The data illustrated in Fig. 4B were obtained from 1-liter cultures grown in 2× YT medium at 37 °C for 12 h. Each culture was inoculated simultaneously then differentially aerated by varying agitation speeds (rpm). After 12 h these cultures were harvested, and the HGb protein was purified. Protein samples were reduced with sodium dithionite, and a visible spectrum was taken. The 0% saturation data illustrated in Fig. 4C was obtained using a sealed 1-liter 2× YT culture where the media and flask were sparged with N2 both before and immediately after inoculation. The 100% saturation data illustrated in Fig. 4C were obtained using a 1-liter 2× YT culture aerated with a 1-liter/min flow of pure O2. Both cultures were agitated at 150 rpm. The heme cofactor was removed from samples of both red and green HGb using the methyl ethyl ketone method to produce the corresponding "green" or "red" apoprotein (24). Titrating the apoprotein sample with hemin chloride solubilized in 0.1 M NaOH generated reconstituted holoproteins.
Kinetic Measurements--
All kinetic experiments were performed
at 20 °C, and protein samples were buffered in 100 mM
potassium phosphate at pH 7.0, unless otherwise specified. Rapid mixing
experiments were conducted using methods described previously (25, 26).
Oxygen dissociation rate constants were measured using both the ligand
displacement reaction (mixing oxygenated samples with carbon monoxide)
and direct observation of oxygen dissociation rate constants (mixing oxygenated samples with solutions of carbon monoxide and sodium dithionite). The flash photolysis apparatus and the methods used to
measure the hexacoordination and bimolecular association rate constants
have been described previously (18, 27, 28). The program Igor Pro
(Wavemetrics, Inc.) was used for curve fitting and generation of figures.
| |
RESULTS |
|---|
|
|
|---|
HGb Identification and Tissue Expression-- The search described under "Experimental Procedures" yielded a candidate gene corresponding to the EST sequence identified by GenBank as R87866. Cloning and subsequent sequencing of R87866 resulted in a 573-bp cDNA coding for the 190-residue protein we term histoglobin. The primary sequence identity shared by HGb with the other principal human Hbs is less than 30%, as is illustrated in the alignment shown in Fig. 2A. Comparative sequence analysis of the HGb cDNA with the NCBI human genomic data base indicates that the gene is located at chromosome 17q25 on the minus strand. The HGb gene structure concomitantly deduced during this analysis indicates that there are four exons interrupted by three introns, as is diagrammed in Fig. 2B.
DNA hybridization results for HGb and NGb are found in Fig.
3. The tissue types corresponding to each
dot in this figure are listed in Table
I. Fig. 3A indicates that HGb
is expressed to a varying degree in all of the tissues represented in
Table I. The expression results for NGb (Fig. 3B) are in
agreement with previously published data showing that this protein is
expressed predominantly only in the tissues of the brain (14).
|
|
Recombinant Protein Generation and Analysis--
Small scale (<1
liter) cultures generating recombinant HGb were grown in shake flasks
to evaluate expression levels. The cell pellets from these cultures, as
well as the protein purified from them, were red in appearance. Scaling
up recombinant protein production by use of the fermentation apparatus
resulted in both cell pellets and HGb protein with a deep pine green
color. The visible spectra of the red and green proteins are shown in
Fig. 4A. The green protein
derives its color from an absorbance band at 630 nm which is lacking in
red HGb and is irreversible in the purified protein. The principal
difference between the cultures grown in the fermentation apparatus and
those grown in shake flasks is the level of oxygen because the
fermentation apparatus is aerated using pure oxygen. A series of
cultures was grown under conditions that varied the level of oxygen,
and the relative color of the resulting proteins was assessed by
spectroscopy. The data from these growths are plotted in Fig. 4,
B and C. The data in Fig. 4C
demonstrate that it is oxygen concentration and not some other aspect
of culture agitation speed which influences the generation of green
HGb. A correlation between the abundance of oxygen during recombinant protein expression and the amount of green protein generated is evident.
|
To assess whether the difference in color originates in the heme cofactor or the globin, apoHGb was generated by removing heme from the red and green proteins. Upon removal, heme from the green protein was green and that from the red protein, red. Reconstitution of the apoprotein generated from green HGb with heme b resulted in holoprotein having a visible spectrum identical to red HGb, as is shown in Fig. 4A. This indicates that the oxygen level-dependent modification giving rise to the green color is associated with the heme cofactor. Additional support of this is the identical size measured for both red and green proteins using SDS-PAGE (data not shown). However, this modification of the heme cofactor had no observable impact on either protein purification or kinetic characteristics of the red and green proteins.
Hexacoordination and Flash Photolysis Kinetics--
Fig.
5 presents an overlay of the absorbance
spectra of reduced, deoxygenated sperm whale Mb, human NGb, and HGb.
The split peak in the visible region is characteristic of a
hexacoordinate heme iron and a signature of the hxHb class of proteins
(29, 30). The HGb absorbance peaks are nearly identical to those of
NGb, suggesting bis-histidyl coordination in the ferrous
deoxygenated form.
|
Time courses for bimolecular ligand recombination with pentacoordinate
Hbs after flash photolysis are described by a single exponential decay.
However, the time courses for ligand binding to hxHbs such as NGb are
not monoexponential because intramolecular coordination competes with
rebinding of the exogenous ligand as described by Reaction 1. In this
reaction, the subscripts H, P, and L refer to the
hexacoordinate, pentacoordinate, and ligand-bound forms of the Hb,
respectively.
|
|
|
|
|
The intercept of these linear fits should be zero if the data reflect
either a simple bimolecular binding reaction (with a slow dissociation
rate constant), or a reaction in which the bimolecular rate constant is
substantially greater than all other binding events
(k'L[L]
kH + k
H) (27). The linear fit to the oxygen binding
data has an intercept within error of zero, indicating that the
reaction measured reflects only the oxygen rebinding event. However,
the linear fit to the CO data in Fig. 6C has a non-zero
intercept at 440 s
1. This suggests that the time courses
giving rise to these data measure a reaction more complex than simple
bimolecular rebinding of CO. As spectroscopic data indicate HGb is
hexacoordinate at equilibrium, the rate constants associated with the
hexacoordination reaction are a likely source of the additional
complexity observed.
Stopped Flow Rapid Mixing Kinetics--
To investigate the
possibility that HGb possesses a hexacoordination dissociation rate
constant (k
H) too slow to be measured with the
flash photolysis method, CO binding was examined using rapid mixing to
initiate the reaction. The time courses for CO binding to the ferrous,
deoxygenated protein at several different concentrations of CO are
shown in Fig. 8A. Although [CO] ranges between 25 and 500 µM, the appearance of
the ligand binding time courses does not show a 20-fold change in
reaction half-time. This phenomenon has been described previously in
hxHbs and is the typical behavior of these proteins (23). These time courses require fitting to a three-exponential decay curve to be
described accurately. The fastest of the rate components was assigned
as the hexacoordination dissociation rate constant
(k
H) in accordance with the mechanism
described in Reaction 1. The slower rate components of these reactions
have been discussed previously in the context of a model for ligand
binding to hxHbs (23). The fastest rate component extracted from the CO
binding time courses is plotted against [CO] in Fig. 8B.
As these values reach an asymptote at ~5 s
1, this value
is reported for k
H in Table II. This
interpretation of the data indicates that the non-zero intercept in
Fig. 6C arises from time courses with a hexacoordination
contribution composed predominantly of the association reaction, and
this is reflected in the reported value of 430 s
1 for
kH in Table II.
|
The HGb O2 and CO dissociation rate constants reported in
Table II were measured with ligand replacement reactions initiated by
stopped-flow rapid mixing (25, 31). Reactions using 1,000 µM [CO] as the displacing ligand and protein samples
saturated under different concentrations of oxygen (262 and 1,250 µM O2) provide corroborating values of 0.35 s
1 for kO2. CO
dissociation experiments used 2,000 µM NO as the displacing ligand and protein samples in less than 50 µM
CO. Under these conditions, kobs is equivalent
to kCO and was measured to be 0.003 s
1 for HGb.
| |
DISCUSSION |
|---|
|
|
|---|
Human Hb and Mb are proteins whose physiological roles in oxygen transport and respiration are among the most clearly defined and well understood. Yet, hxHbs have thus far demonstrated oxygen affinities that preclude their functioning within these roles (12, 15, 18, 21, 29). From its biophysical behavior to the tissues within which it is expressed, HGb exhibits fundamental differences from the other human Hbs. The discussion that follows examines these differences in the context of potential physiological significance.
Primary Structure Comparison-- Comparison of the nucleic acid and protein sequences of HGb with the other human Hbs highlights both the similarities and differences that characterize this protein. A primary sequence alignment of the human Hbs (Fig. 2A) illustrates that HGb shares many of the elements that are common to the vertebrate globins, including the invariant proximal HisF8 (the eighth amino acid along the F helix with reference to the structure of myoglobin) PheCD1, and the distal HisE7. The amino acids comprising the heme pocket in HGb appear to have more in common with pentacoordinate Mb than with NGb. For example, the E6 residue in the distal heme pocket of HGb and Mb is a Lys, in contrast to the Asp residue occupying this position in NGb; the F9 position adjacent to the proximal His in NGb contains a polar residue, as opposed to the aliphatic side chains in this position in Mb and HGb. The similarities in the heme pocket primary structure between Mb and HGb are intriguing, particularly in the context of the nearly identical O2 and CO equilibrium affinity constants for these proteins (Table II).
Most Hb genes contain two conserved introns at positions B12-2 (between nucleotides 2 and 3 of the codon for amino acid B12) and G7-0. A third intron at position E11-0 is conserved in all plant Hbs and also found in NGb (14, 32, 33). As illustrated in Fig. 2B, HGb contains three introns, as do all other hxHbs. However, although two of these introns are located at the conserved B12-2 and G7-0 positions, the location of the third intron at H36-2 is unprecedented. The three-intron gene structure found in hxHbs is believed to indicate an earlier evolutionary origin than pentacoordinate mammalian Hbs (33). Perhaps HGb represents an intermediate evolutionary step between the more recently evolved pentacoordinate Hbs and other hxHbs such as NGb and the nonsymbiotic plant Hbs.
As is the case with NGb, there are putative HGb genes in both the rat and mouse which are highly homologous to the human version. The putative mouse HGb gene arises from an EST sequence (accession no. AK019410), and the rat homolog was noted in a very recent proteomic study where it was called Stellate Cell Activation-associated Protein (STAP) (34). Considering the numerous genes already bearing this acronym (35-37), the characterization of HGb as a hxHb and its expression in many tissues besides hepatic stellate cells, it seemed logical to continue our reference to this gene as HGb. The human HGb primary structure shares more than 90% identity with its homologs in the rat and mouse. This high degree of conservation implies that the function of these proteins is rigidly dependent upon the specific functional properties conveyed by these particular structures.
Hexacoordination and Ligand Binding-- A key element in learning the physiological role(s) held by HGb, as well as other hxHbs, is biophysical study of the attributes that define the behavior of these proteins. The spectroscopic analysis of reduced, deoxygenated HGb (Fig. 5) clearly distinguishes it from pentacoordinate Mb. The Soret peak wavelengths of HGb are nearly identical to those of NGb, and these spectra illustrate the difference between the coordination states of these hxHbs and pentacoordinate Mb.
In addition to the equilibrium spectral signature, another manifestation of hexacoordinate character is biphasic time courses for ligand rebinding following flash photolysis (27, 28). However, the appearance of these biphasic time courses depends upon the relationship between the rate constants of hexacoordination and bimolecular ligand binding. If hexacoordination is outcompeted by bimolecular ligand rebinding, then single exponential time courses will be observed (27). The time courses illustrated in Figs. 6B and 7B exhibit this single exponential form and indicate that the rates associated with hexacoordination in HGb must be considerably slower than those of NGb (28). However, the non-zero intercept in Fig. 6C suggests that CO rebinding rate constants at the lowest concentrations of CO were of an order similar to that of the HGb rate constants for hexacoordination. A more quantitative assessment of these values in HGb is possible if this intercept could be correlated with data from an independent method of measuring hexacoordination rate constants. These data were obtained using stopped-flow rapid mixing to ascertain the magnitude of the hexacoordination dissociation rate constant (Fig. 8).
The intercept from Fig. 6C (~kH) and the
approximate asymptote value from Fig. 8B
(~k
H) can be correlated with Equation 1,
which describes the expected rate constant for ligand binding initiated
by rapid mixing according to the mechanism described in Reaction 1 (23).
|
(Eq. 1) |
H to
the fastest phase of ligand binding observed after rapid mixing.
The rate constants associated with hexacoordination in HGb are
considerably smaller than those observed thus far in other hxHbs (18,
27, 28). The effect of hexacoordination on equilibrium affinity
constants can be calculated using the following equation, where
KL,Pent is the equilibrium constant for ligand
association to the pentacoordinate form of the protein
(k'L/kL), and
KH is the equilibrium constant for
hexacoordination
(kH/k
H) (28).
|
(Eq. 2) |
Formation of Green HGb-- Green heme proteins are not unprecedented, and their color can arise through several different mechanisms. 1) Myeloperoxidase contains a conventional heme cofactor that is covalently attached to the protein by two methoxy esters and a methionine-derived sulfonium linkage. Coupled with a nonplanar bend in the heme, these linkages are believed to be the origin of its green color (38). 2) Biliverdin and verdoheme are green heme derivatives produced by heme oxygenase during the degradation of heme (39). 3) Sulfhemoglobin (sulfHb), a green protein associated with certain blood pathologies, owes its color to the incorporation of sulfur into the porphyrin ring, forming sulfhemin (40).
The green color in HGb is caused by a heme modification, because the addition of iron protoporphyrin IX to (previously green) apoHGb results in red protein. Additionally, red HGb is stable and does not degrade to the green protein. This suggests that green HGb is not a result of mechanisms 1) and 2) described above. However, it is possible that green HGb is a sulfHb. In support of this view is the fact that formation of sulfHbs is known to be dependent on the availability of oxygen (40), as we have shown to be the case with formation of green HGb. And like sulfHb, the absorbance spectrum of green HGb is very similar to that of the red protein (41), containing only the additional peak around 630 nm. However, sulfmyoglobin is associated with 2,500- and 10-fold reductions in O2 and CO binding, respectively (42, 43). In marked contrast to this, green HGb appears to differ little from red HGb in ligand binding behavior. It is possible that the reaction time courses we observed for green HGb are attributable to the presence of a fraction of the red protein. Yet, if this were the case, smaller absorbance change amplitudes would be expected for the CO and O2 ligand binding reactions with the green protein compared with the red, and this difference was not observed (data not shown).
The mechanism for generation of sulfHbs involves a ferryl heme iron and sulfide (41). Given the conditions under which it is generated, if green HGb is a sulfHb it must either have a more stable ferryl oxidation state compared with other Hbs or harbor a readily accessible sulfur atom. In support of the latter is a cysteine located in the distal heme pocket (position E9) which might facilitate sulfheme formation. With regard to the former, a ferryl heme iron is a component of peroxidase compound I, and HGb has been attributed peroxidase activity (34). However, the level of activity is very low compared with known peroxidases (44). In fact, the level of peroxidase activity attributed to HGb is similar to the "pseudo" peroxidase activity of other Hbs including Mb and soybean leghemoglobin (45, 46). This suggests that the primary role of HGb is not that of a peroxidase.
Physiological Significance-- The transport and facilitated diffusion of oxygen and other ligands by Hbs have been subjects of investigation since the 1960s (47, 48). The relationship between Hb kinetic rate constants and the environment in which the protein functions is fairly well established for these physiological roles (49-51). Although other hxHbs characterized thus far possess oxygen affinities that are too high for these functions, the oxygen affinity of HGb is of the same order as Mb and should allow it to serve in a similar role. It is therefore possible that HGb supports the facilitated diffusion of oxygen in those tissues that do not express Mb. In this scenario, hexacoordination would serve simply to decrease oxygen affinity, thereby allowing transport to a higher affinity oxidase.
Another hypothesis is that hxHbs (including HGb) are involved in a general mechanism for scavenging NO and/or other reactive oxygen species in both plants and animals. Plant hxHbs and NGb are both up-regulated by hypoxia (10, 19, 20). Expression of plant hxHbs is also stimulated by conditions that activate the plant disease resistance pathway (52-54), which generates NO and other reactive oxygen species (55, 56). Reperfusion injury following ischemia in animals has been associated with NO (57); it is intriguing that both plants and animals express biochemically similar hxHbs in response to this type of challenge.
The expression of HGb has not yet been linked with hypoxia. Nevertheless, this possibility is interesting in the context of the oxygen-dependent modification of the heme cofactor. Although this modification may be an artifact of recombinant expression, it has not been observed during the generation of other recombinant Hbs in this laboratory. It has been proposed previously that hxHbs may play a role in sensing gaseous ligands (29, 58). If HGb serves this function, the heme modification may be a component of the sensory mechanism.
Conclusions--
The study of HGb presented here identifies a new
human gene that encodes a member of a biophysically defined class of
proteins called hexacoordinate Hbs. These proteins are found in most
organisms and possess a regulatory ligand binding mechanism that
differs fundamentally from traditional pentacoordinate Hbs. In HGb this mechanism results in exogenous ligand equilibrium affinity constants that are very similar to those of Mb. And although considerable uncertainty remains as to the physiological role(s) served by HGb or
the other hxHbs, mounting evidence suggests a potential protective
function during conditions of oxidative stress.
| |
ACKNOWLEDGEMENTS |
|---|
We thank Drs. Robert Thornburg and Clay Carter for providing expertise and assistance with the hybridization experiments and Dr. Cyril Appleby for helpful suggestions and a careful reading of this manuscript.
| |
Note Added in Proof |
|---|
While this manuscript was in press, another article describing this gene was published (Burmester, T., Ebner, B., Weich, B., and Hankeln, T. (2002) Mol. Biol. Evol. 19, 416-421).
| |
FOOTNOTES |
|---|
* This work was funded in part by United States Department of Agriculture Grant 99-35306-7833.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
To whom correspondence should be addressed: Dept. of Biochemistry,
Biophysics, and Molecular Biology, 4114 Molecular Biology Bldg., Iowa
State University, Ames, IA 50011. Tel.: 515-294-2616; Fax:
515-294-0453; E-mail: msh@iastate.edu.
Published, JBC Papers in Press, March 13, 2002, DOI 10.1074/jbc.M201934200
| |
ABBREVIATIONS |
|---|
The abbreviations used are: Hb(s), hemoglobin(s); EST, expressed sequence tag; HGb, histoglobin; hxHb, hexacoordinate Hb; Mb, myoglobin; NGb, neuroglobin; NO, nitric oxide; sulfHb, sulfhemoglobin.
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Gardner, P. R.,
Gardner, A. M.,
Martin, L. A.,
and Salzman, A. L.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
10378-10383 |
| 2. |
Hausladen, A.,
Gow, A.,
and Stamler, J.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
14100-14105 |
| 3. |
Membrillo-Hernandez, J.,
Coopamah, M.,
Anjum, M.,
Stevanin, T.,
Kelly, A.,
Hughes, M.,
and Poole, R.
(1999)
J. Biol. Chem.
274,
748-754 |
| 4. | Doherty, D., Doyle, M. P., Curry, S. R., Vali, R., Fattor, T., Olson, J., and Lemon, D. (1998) Nat. Biotechnol. 16, 672-676[CrossRef][Medline] [Order article via Infotrieve] |
| 5. | Brunori, M. (2001) Trends Biochem. Sci. 26, 21-23[CrossRef][Medline] [Order article via Infotrieve] |
| 6. |
Flogel, U.,
Merx, M.,
Godecke, A.,
Decking, U.,
and Schrader, J.
(2001)
Proc. Natl. Acad. Sci. U. S. A.
98,
735-740 |
| 7. | Minning, D., Gow, A., Bonaventura, J., Braun, R., Dewhirst, M., Goldberg, D., and Stamler, J. (1999) Nature 401, 497-502[CrossRef][Medline] [Order article via Infotrieve] |
| 8. |
Couture, M.,
Yeh, S.,
Wittenberg, B. A.,
Wittenberg, J. B.,
Ouellet, Y.,
Rousseau, D. L.,
and Guertin, M.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
11223-11228 |
| 9. | Jia, L., Bonaventura, C., Bonaventura, J., and Stamler, J. (1996) Nature 380, 221-226[CrossRef][Medline] [Order article via Infotrieve] |
| 10. |
Sun, Y.,
Jin, K.,
Mao, X.,
Zhu, Y.,
and Greenberg, D. A.
(2001)
Proc. Natl. Acad. Sci. U. S. A.
98,
15306-15311 |
| 11. | Taylor, E. R., Nie, X. Z., Alexander, W. M., and Hill, R. D. (1994) Plant Mol. Biol. 24, 853-862[CrossRef][Medline] [Order article via Infotrieve] |
| 12. |
Trevaskis, B.,
Watts, R. A.,
Andersson, C. R.,
Llewellyn, D. J.,
Hargrove, M. S.,
Olson, J. S.,
Dennis, E. S.,
and Peacock, W. J.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
12230-12234 |
| 13. | Awenius, C., Hankeln, T., and Burmester, T. (2001) Biochem. Biophys. Res. Commun. 287, 418-421[CrossRef][Medline] [Order article via Infotrieve] |
| 14. | Burmester, T., Welch, B., Reinhardt, S., and Hankeln, T. (2000) Nature 407, 520-523[CrossRef][Medline] [Order article via Infotrieve] |
| 15. |
Couture, M.,
Das, T. K.,
Lee, H. C.,
Peisach, J.,
Rousseau, D. L.,
Wittenberg, B. A.,
Wittenberg, J. B.,
and Guertin, M.
(1999)
J. Biol. Chem.
274,
6898-6910 |
| 16. | Scott, N., and LeComte, J. (2000) Protein Sci. 3, 587-597 |
| 17. | Couture, M., Das, T., Savard, P., Ouellet, Y., Wittenberg, J., Wittenberg, B., Rousseau, D., and Guertin, M. (2000) Eur. J. Biochem. 267, 4770-4780[Medline] [Order article via Infotrieve] |
| 18. |
Hvitved, A. N.,
Trent, J. T., III.,
Premer, S. A.,
and Hargrove, M. S.
(2001)
J. Biol. Chem.
276,
34714-34721 |
| 19. |
Arredondo-Peter, R.,
Hargrove, M. S.,
Moran, J. F.,
Sarath, G.,
and Klucas, R. V.
(1998)
Plant Physiol.
118,
1121-1125 |
| 20. | Hunt, P. W., Watts, R. A., Trevaskis, B., Llewellyn, D. J., Burnell, J., Dennis, E. S., and Peacock, W. J. (2001) Plant Mol. Biol. 47, 677-692[CrossRef][Medline] [Order article via Infotrieve] |
| 21. | Hargrove, M., Brucker, E., Stec, B., Sarath, G., Arredondo-Peter, R., Klucas, R., Olson, J., and Phillips, G. (2000) Struct. Fold. Des. 8, 1005-1014[Medline] [Order article via Infotrieve] |
| 22. | Computational Biology and Informatics Laboratory. (2001) ALLGENE, Version 2.2 , Center for Bioinformatics, University of Pennsylvania |
| 23. | Trent, J. T., III, Hvitved, A. N., and Hargrove, M. S. (2001) Biochemistry 40, 6155-6163[CrossRef][Medline] [Order article via Infotrieve] |
| 24. | Ascoli, F., Rosaria, M., Fanelli, M. R., and Antonini, E. (1981) Methods Enzymol. 76, 72-77[Medline] [Order article via Infotrieve] |
| 25. | Olson, J. S. (1981) Methods Enzymol. 76, 631-651[Medline] [Order article via Infotrieve] |
| 26. |
Goodman, M. D.,
and Hargrove, M. S.
(2001)
J. Biol. Chem.
276,
6834-6839 |
| 27. |
Hargrove, M. S.
(2000)
Biophys. J.
79,
2733-2738 |
| 28. |
Trent, J. T., III,
Watts, R. A.,
and Hargrove, M. S.
(2001)
J. Biol. Chem.
276,
30106-30110 |
| 29. | Arredondo-Peter, R., Hargrove, M. S., Sarath, G., Moran, J. F., Lohrman, J., Olson, J. S., and Klucas, R. V. (1997) Plant Physiol. 115, 1259-1266[Abstract] |
| 30. |
Duff, S. M. G.,
Wittenberg, J. B.,
and Hill, R. D.
(1997)
J. Biol. Chem.
272,
16746-16752 |
| 31. | Quillin, M. L., Li, T., Olson, J. S., Phillips, G. N., Jr., Dou, Y., Ikeda-Saito, M., Regan, R., Carlson, M., Gibson, Q. H., Li, H., and Elber, R. (1995) J. Mol. Biol. 245, 416-436[CrossRef][Medline] [Order article via Infotrieve] |
| 32. |
Hyldig-Nielsen, J.,
Jensen, E.,
Paludan, K.,
Wiborg, O.,
Garrett, R.,
Jorgensen, P.,
and Marcker, K.
(1982)
Nucleic Acids Res.
10,
689-701 |
| 33. |
Hardison, R. C.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
5675-5679 |
| 34. |
Kawada, N.,
Kristensen, D.,
Asahina, K.,
Nakatani, K.,
Minamiyama, Y.,
Seki, S.,
and Yoshizato, K.
(2001)
J. Biol. Chem.
276,
25318-25323 |
| 35. | Ohuchi, J., Ara, T., Kon, Y., Asano, A., Yamauchi, H., and Watanabe, T. (2001) Mol. Reprod. Dev. 59, 350-358[CrossRef][Medline] [Order article via Infotrieve] |
| 36. | Masuhara, M., Nagao, K., Nishikawa, M., Sasaki, M., Yoshimura, A., and Osawa, M. (2000) Biochem. Biophys. Res. Commun. 268, 697-703[CrossRef][Medline] [Order article via Infotrieve] |
| 37. | Bertin, A. (1992) J. Med. Microbiol. 37, 141-147[Abstract] |
| 38. | Babior, B. M. (1999) in Reactive Oxygen Species in Biological Systems (Gilbert, D. L. , and Colton, C. A., eds) , Kluwer Academic, New York |
| 39. | O'Carra, P. (1976) in Porphyrins and Metalloporphyrins (Smith, K. M., ed) , Elsevier Science Publishers B.V., Amsterdam |
| 40. |
Berzofsky, J. A.,
Peisach, J.,
and Blumberg, W. E.
(1971)
J. Biol. Chem.
246,
3367-3377 |
| 41. |
Berzofsky, J. A.,
Peisach, J.,
and Horecker, B. L.
(1972)
J. Biol. Chem.
247,
3783-3791 |
| 42. |
Berzofsky, J. A.,
Peisach, J.,
and Blumberg, W. E.
(1971)
J. Biol. Chem.
246,
7366-7372 |
| 43. |
Berzofsky, J. A.,
Peisach, J.,
and Alben, J. O.
(1972)
J. Biol. Chem.
247,
3774-3782 |
| 44. | Dunford, B. H. (1999) Heme Peroxidases , John Wiley & Sons, New York |
| 45. | Sievers, G., and Ronnberg, M. (1978) Biochim. Biophys. Acta 533, 293-301[Medline] [Order article via Infotrieve] |
| 46. | Puppo, A., Rigaud, J., Job, D., Ricard, J., and Zeba, B. (1980) Biochim. Biophys. Acta 614, 303-312[Medline] [Order article via Infotrieve] |
| 47. |
Wittenberg, B.
(1966)
J. Biol. Chem.
241,
104-114 |
| 48. |
Wyman, J.
(1966)
J. Biol. Chem.
241,
115-121 |
| 49. | Appleby, C. A. (1984) Annu. Rev. Plant Physiol. 35, 443-478[CrossRef] |
| 50. |
Murray, J.,
and Wyman, J.
(1971)
J. Biol. Chem.
246,
5903-5906 |
| 51. |
Wittenberg, J. B.,
Appleby, C. A.,
and Wittenberg, B. A.
(1972)
J. Biol. Chem.
247,
527-531 |
| 52. |
Helleboid, S.,
Hendriks, T.,
Bauw, G.,
Inze, D.,
Vasseur, J.,
and Hilbert, J.
(2000)
J. Exp. Bot.
51,
1189-1200 |
| 53. | Herbers, K., Meuwly, P., Metraux, J. P., and Sonnewald, U. (1996) FEBS Lett. 397, 239-244[CrossRef][Medline] [Order article via Infotrieve] |
| 54. | Lorberth, R., Dammann, C., Ebneth, M., Amati, S., and Sanchez-Serrano, J. J. (1992) Plant J. 2, 477-486[Medline] [Order article via Infotrieve] |
| 55. | Delledonne, M., Xia, Y., Dixon, R. A., and Lamb, C. (1998) Nature 394, 585-588[CrossRef][Medline] [Order article via Infotrieve] |
| 56. |
Delledonne, M.,
Zeier, J.,
Marocco, A.,
and Lamb, C.
(2001)
Proc. Natl. Acad. Sci. U. S. A.
98,
13454-13459 |
| 57. | Fukuto, J., and Wink, D. (1999) Metal Ions Biol. Syst. 36, 547-595 |
| 58. |
Weber, R. E.,
and Vinogradov, S.
(2001)
Physiol. Rev.
81,
569-628 |
| 59. | Whitaker, T. L., Berry, M. B., Ho, E. L., Hargrove, M. S., Phillips, G. N., Jr., Komiyama, N. H., Nagai, K., and Olson, J. S. (1995) Biochemistry 34, 8221-8226[CrossRef][Medline] [Order article via Infotrieve] |
| 60. | Springer, B. A., Sligar, S. G., Olson, J. S., and Phillips, G. N., Jr. (1994) Chem. Rev. 94, 699-714[CrossRef] |
This article has been cited by other articles:
![]() |
T. Yamashita, L. Bouzhir-Sima, J.-C. Lambry, U. Liebl, and M. H. Vos Ligand Dynamics and Early Signaling Events in the Heme Domain of the Sensor Protein Dos from Escherichia coli J. Biol. Chem., January 25, 2008; 283(4): 2344 - 2352. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Hamdane, C. Vasseur-Godbillon, V. Baudin-Creuza, G. H. B. Hoa, and M. C. Marden Reversible Hexacoordination of {alpha}-Hemoglobin-stabilizing Protein (AHSP)/{alpha}-Hemoglobin Versus Pressure: EVIDENCE FOR PROTECTION OF THE {alpha}-CHAINS BY THEIR CHAPERONE J. Biol. Chem., March 2, 2007; 282(9): 6398 - 6404. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Hoy, B. J. Smagghe, P. Halder, and M. S. Hargrove Covalent heme attachment in Synechocystis hemoglobin is required to prevent ferrous heme dissociation Protein Sci., February 1, 2007; 16(2): 250 - 260. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. P.A. Mammen, J. M. Shelton, Q. Ye, S. B. Kanatous, A. J. McGrath, J. A. Richardson, and D. J. Garry Cytoglobin Is a Stress-responsive Hemoprotein Expressed in the Developing and Adult Brain J. Histochem. Cytochem., December 1, 2006; 54(12): 1349 - 1361. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Xinarianos, F. E. McRonald, J. M. Risk, N. L. Bowers, G. Nikolaidis, J. K. Field, and T. Liloglou Frequent genetic and epigenetic abnormalities contribute to the deregulation of cytoglobin in non-small cell lung cancer Hum. Mol. Genet., July 1, 2006; 15(13): 2038 - 2044. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ostojic, D. S. Sakaguchi, Y. de Lathouder, M. S. Hargrove, J. T. Trent III, Y. H. Kwon, R. H. Kardon, M. H. Kuehn, D. M. Betts, and S. Grozdanic Neuroglobin and cytoglobin: oxygen-binding proteins in retinal neurons. Invest. Ophthalmol. Vis. Sci., March 1, 2006; 47(3): 1016 - 1023. [Abstract] [Full Text] [PDF] |
||||